Clinical research, healthcare systems, and the medical applications of AI dominate discussion on the second day of the three-day conclave.
AstraZeneca
Scientists aim to confirm if Sinopharm can be ‘mixed and matched’ with AstraZeneca jabs in an attempt to ease supply problems.
SSM calls for further investigation after possible link detected between AstraZeneca and blood clots.
